desipramine has been researched along with methadone in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (39.53) | 18.7374 |
1990's | 12 (27.91) | 18.2507 |
2000's | 8 (18.60) | 29.6817 |
2010's | 6 (13.95) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Nagashima, R; Nishikawa, T; Tobita, M | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Mason, MF | 1 |
Lin, HL; Medzihradsky, F | 1 |
Evans, DB; Liu, SJ; Wang, RI | 2 |
Chen, KZ; Liu, SJ; Wang, RI | 1 |
Liu, SJ; Wang, RI | 2 |
Brown, BS; Haertzen, CC; Jaffe, JH; Kolar, AF; Michaelson, BS; Weddington, WW | 1 |
Brooke, D; Fudala, PJ; Johnson, RE | 1 |
Arndt, IO; Dorozynsky, L; McLellan, AT; O'Brien, CP; Woody, GE | 2 |
Falcione, J; Kosten, TR; Morgan, CM; Schottenfeld, RS | 1 |
Meyer, RE | 1 |
Kosten, TR; Morgan, CH; Schottenfeld, RS | 1 |
Gawin, FH; Jatlow, P; Kosten, TR; Morgan, C; Nelson, JC | 2 |
Arndt, IO; Burke, W; Dhopesh, V; Maany, I; O'Brien, CP; Woody, G | 1 |
Arndt, I; Dorozynsky, L; McLellan, AT; O'Brien, CP; Woody, G | 1 |
Alterman, A; Childress, AR; McLellan, AT; O'Brien, CP; Walter, D | 1 |
Gawin, F; Kosten, T; Schumann, B | 1 |
Baumann, P; Cuendet, C; Eap, CB | 1 |
Carney, MK; Gawin, FH; Kosten, TR; Schumann, B; Wright, D | 1 |
Affrime, M; Reidenberg, MM | 1 |
Carmichael, FJ; Israel, Y | 1 |
Garriott, JC; Stolman, A | 1 |
Cleary, J; Kovera, CA; Overmier, JB; Schaal, DW; Thompson, T | 1 |
Kosten, T; Leal, J; Ziedonis, D | 1 |
Feingold, A; Kosten, TR; Oliveto, A; Schottenfeld, R | 1 |
Feingold, A; Jatlow, P; Kosten, TR; Oliveto, AH; Schottenfeld, R | 1 |
Berrocoso, E; Gibert-Rahola, J; Micó, JA; Rojas-Corrales, MO | 1 |
Gibert-Rahola, J; Mico, JA; Rojas-Corrales, MO | 1 |
Patel, TA; Rastogi, R; Swarm, RA | 1 |
Barak, Y; Baratz-Goldstein, R; Hostovsky, A; Pick, CG; Rubovitch, V; Schreiber, S; Volis, I | 1 |
4 review(s) available for desipramine and methadone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug impairment reviews: opiates, minor tranquilizers.
Topics: Amitriptyline; Anti-Anxiety Agents; Automobile Driving; Behavior; Desipramine; Dextropropoxyphene; Diazepam; Ethanol; Humans; Imipramine; Lithium; Methadone; Motor Skills; Narcotics; Task Performance and Analysis | 1977 |
New pharmacotherapies for cocaine dependence ... revisited.
Topics: Alcoholism; Cocaine; Desipramine; Disease Models, Animal; Double-Blind Method; Heroin Dependence; Humans; Methadone; Randomized Controlled Trials as Topic; Substance-Related Disorders | 1992 |
Case scenario: opioid association with serotonin syndrome: implications to the practitioners.
Topics: Analgesics, Opioid; Antidepressive Agents, Tricyclic; Celecoxib; Chronic Pain; Cyclooxygenase 2 Inhibitors; Depressive Disorder; Desipramine; Drug Interactions; Duloxetine Hydrochloride; Fentanyl; Humans; Male; Methadone; Middle Aged; Oxycodone; Polypharmacy; Pyrazoles; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sulfonamides; Thiophenes; Transdermal Patch | 2011 |
11 trial(s) available for desipramine and methadone
Article | Year |
---|---|
Treatment of cocaine dependence in methadone maintenance clients: a pilot study comparing the efficacy of desipramine and amantadine.
Topics: Adolescent; Adult; Amantadine; Baltimore; Cocaine; Desipramine; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Pilot Projects; Placebos; Research Design; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Substance-Related Disorders; United States | 1992 |
Weighing up the pros and cons: help-seeking by drug misusers in Baltimore, USA.
Topics: Adult; Bromocriptine; Buprenorphine; Cocaine; Desipramine; Fear; Female; Fluoxetine; Humans; Male; Methadone; Middle Aged; Motivation; Opioid-Related Disorders; Patient Acceptance of Health Care; Phencyclidine Abuse; Substance Abuse Treatment Centers; Substance-Related Disorders; Urban Population | 1992 |
Desipramine treatment of cocaine dependence in methadone-maintained patients.
Topics: Adult; Cocaine; Comorbidity; Desipramine; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Patient Dropouts; Placebos; Severity of Illness Index; Substance Abuse Detection; Substance-Related Disorders; Treatment Outcome | 1992 |
Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine.
Topics: Adult; Amantadine; Cocaine; Desipramine; Double-Blind Method; Female; Humans; Male; Methadone; Opioid-Related Disorders; Placebos; Substance Abuse Detection; Substance-Related Disorders; Treatment Outcome | 1992 |
Amantadine and desipramine in the treatment of cocaine abusing methadone maintained patients.
Topics: Adult; Amantadine; Cocaine; Desipramine; Double-Blind Method; Female; Humans; Male; Methadone; Opioid-Related Disorders; Substance-Related Disorders | 1990 |
Desipramine treatment of cocaine abuse in methadone maintenance patients.
Topics: Clinical Trials as Topic; Cocaine; Combined Modality Therapy; Desipramine; Double-Blind Method; Humans; Male; Methadone; Opioid-Related Disorders; Substance-Related Disorders | 1989 |
Evaluation of treatment for cocaine dependence.
Topics: Adult; Behavior Therapy; Cocaine; Combined Modality Therapy; Desipramine; Double-Blind Method; Humans; Male; Methadone; Randomized Controlled Trials as Topic; Substance-Related Disorders; Veterans | 1989 |
Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence.
Topics: Adult; Amantadine; Antisocial Personality Disorder; Cocaine; Combined Modality Therapy; Comorbidity; Depressive Disorder; Desipramine; Double-Blind Method; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Patient Dropouts; Substance Abuse Detection; Substance-Related Disorders | 1994 |
Desipramine treatment for cocaine dependence. Role of antisocial personality disorder.
Topics: Adult; Antisocial Personality Disorder; Cocaine; Comorbidity; Desipramine; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Substance-Related Disorders; Treatment Outcome | 1994 |
Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers.
Topics: Adult; Analgesics, Opioid; Antidepressive Agents, Tricyclic; Buprenorphine; Clinical Trials as Topic; Cocaine-Related Disorders; Cross-Over Studies; Desipramine; Double-Blind Method; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Placebos; Time Factors; Treatment Outcome | 2002 |
Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
Topics: Adult; Analgesics, Opioid; Antidepressive Agents, Tricyclic; Buprenorphine; Cocaine-Related Disorders; Comorbidity; Desipramine; Drug Administration Schedule; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Sex Factors; Treatment Outcome | 1999 |
28 other study(ies) available for desipramine and methadone
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Inhibition of cellular atp-hydrolyzing activity by tricyclic antidepressants and phenothiazine tranquilizers.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Amphetamine; Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Blood Platelets; Brain; Cattle; Desipramine; Kidney Cortex; Leukocytes; Male; Methadone; Microsomes; Neurons; Phenothiazines; Rats; Structure-Activity Relationship | 1975 |
Correlation of urinary excretion of methadone metabolites with methadone metabolism and analgesia in the rat.
Topics: Analgesics; Animals; Biotransformation; Desipramine; Diazepam; Drug Interactions; Male; Methadone; Phenobarbital; Rats; Reaction Time; Time Factors; Tissue Distribution | 1978 |
Determination of urinary excretion of a methadone metabolite as an indirect measurement of methadone metabolism in the rat.
Topics: Animals; Desipramine; Liver; Male; Methadone; Phenobarbital; Rats; Time Factors | 1978 |
Effects of desipramine treatment on the biliary, fecal and urinary excretion of methadone in the rat.
Topics: Animals; Bile; Desipramine; Feces; Male; Methadone; Rats; Time Factors | 1976 |
Increased analgesia and alterations in distribution and metabolism of methadone by desipramine in the rat.
Topics: Analgesia; Animals; Brain; Desipramine; Drug Synergism; In Vitro Techniques; Kidney; Lethal Dose 50; Liver; Lung; Male; Methadone; Microsomes, Liver; Oxidoreductases, N-Demethylating; Phenobarbital; Rats; Reaction Time; Time Factors | 1975 |
Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse.
Topics: Adult; Cocaine; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Female; Humans; Male; Methadone; Middle Aged; Substance-Related Disorders | 1990 |
Desipramine and its 2-hydroxy metabolite in patients taking or not taking methadone.
Topics: Desipramine; Drug Interactions; Humans; Hydroxylation; Methadone; Opioid-Related Disorders | 1990 |
Increase in desipramine serum levels associated with methadone treatment.
Topics: Adult; Cocaine; Desipramine; Drug Interactions; Drug Therapy, Combination; Humans; Male; Methadone; Opioid-Related Disorders; Substance-Related Disorders | 1989 |
Treating cocaine abusing methadone maintenance patients with desipramine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cocaine; Desipramine; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Substance-Related Disorders | 1988 |
Selectivity in the binding of psychotropic drugs to the variants of alpha-1 acid glycoprotein.
Topics: Amitriptyline; Clomipramine; Desipramine; Hydrogen-Ion Concentration; Imipramine; Maprotiline; Methadone; Orosomucoid; Psychotropic Drugs; Thioridazine; Trimipramine | 1988 |
A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients.
Topics: Adult; Antisocial Personality Disorder; Black or African American; Cocaine; Desipramine; Female; Humans; Male; Methadone; Opioid-Related Disorders; Substance-Related Disorders | 1987 |
Enhanced development of dispositional tolerance to methadone by desipramine given together with methadone.
Topics: Analgesia; Animals; Desipramine; Drug Interactions; Humans; Male; Methadone; Rats; Rats, Inbred Strains; Substance-Related Disorders; Time Factors | 1985 |
Influence of disease on binding of drugs to plasma proteins.
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Blood Proteins; Blood Urea Nitrogen; Carbon Radioisotopes; Creatinine; Dapsone; Desipramine; Dialysis; Fluoresceins; Heart Failure; Humans; Hypoproteinemia; Liver Cirrhosis; Male; Methadone; Pharmaceutical Preparations; Phenytoin; Protein Binding; Quinidine; Triamterene; Ultrafiltration; Uremia | 1973 |
In vitro inhibitory effects of narcotic analgesics and other psychotropic drugs on the active uptake of norepinephrine in mouse brain tissue.
Topics: Animals; Atropine; Benztropine; Brain; Chlorpromazine; Cocaine; Codeine; Desipramine; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Levorphanol; Lipids; Meperidine; Methadone; Mice; Morphine; Naloxone; Narcotics; Norepinephrine; Solubility; Synaptosomes; Tritium | 1973 |
Detection of some psychotherapeutic drugs and their metabolites in urine.
Topics: Amitriptyline; Amphetamine; Analgesics; Antidepressive Agents; Chlordiazepoxide; Chlorpromazine; Chromatography, Thin Layer; Desipramine; Diazepam; Fluphenazine; Haloperidol; Humans; Imipramine; Indicators and Reagents; Methadone; Perphenazine; Solvents; Thioridazine; Tranquilizing Agents; Trifluoperazine | 1971 |
Behavioral and neurochemical mechanisms of opioid-antidepressant interactions.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain Chemistry; Columbidae; Conditioning, Operant; Desipramine; Dose-Response Relationship, Drug; Endorphins; Female; Imipramine; Methadone; Norepinephrine; Reinforcement Schedule | 1994 |
Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Blepharoptosis; Body Temperature; Cyclohexanols; Desipramine; Fluvoxamine; Levorphanol; Male; Methadone; Mice; Morphine; Narcotics; Reserpine; Stereoisomerism; Time Factors; Tramadol; Venlafaxine Hydrochloride | 2004 |
Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.
Topics: 5-Hydroxytryptophan; Analgesics, Opioid; Animals; Clozapine; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Fluvoxamine; Indophenol; Levorphanol; Male; Methadone; Mice; Morphine; Naloxone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Piperazines; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Stereotyped Behavior; Tics; Tourette Syndrome; Tramadol; Triazoles | 2007 |
Interaction of different antidepressants with acute and chronic methadone in mice, and possible clinical implications.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Citalopram; Clomipramine; Cyclohexanols; Desipramine; Drug Interactions; Fluvoxamine; Male; Methadone; Mice; Mice, Inbred ICR; Morpholines; Nociception; Pain Threshold; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2014 |